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http://dx.doi.org/10.1016/j.kjms.201Abstract Chronic exposure to inorganic arsenic trioxide causes tumors of the skin, urinary
bladder, lung, and liver. Several cancer initiators and promoters have been shown to alter
cellecell signaling by interference with gap junction intercellular communication (GJIC)
and/or modulation of cell adhesion molecules, such as connexin43 (Cx43), E-cadherin, and
b-catenin. The aim of this study was to determine whether the disruption of cellecell interac-
tions occurs in liver epithelial cells after exposure to arsenic trioxide. WB-F344 cells were
treated with arsenic trioxide (6.25e50 mM) for up to 8 hours, and gap junction function was
analyzed using the scrape-load/dye transfer assay. In addition, the changes in mRNA and pro-
tein levels of Cx43, E-cadherin, and b-catenin were determined. A significant dose- and time-
dependent decrease in GJIC was observed when WB-F344 cells were exposed to arsenic
trioxide (p < 0.05). Consistent with the inhibition of GJIC, cells’ exposure to arsenic trioxide
resulted in dose- and time-dependent decreases in Cx43 and E-cadherin mRNA expression andhave no conflicts of interest relevant to this article.
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58 P.-J. Hsiao et al.protein levels. However, arsenic trioxide did not alter the mRNA or protein levels of b-catenin.
In an immunofluorescence study, nuclei were heavily stained with anti-b-catenin antibody,
indicating significant nuclear translocation. In this study, we also demonstrated that arsenic
trioxide-induced GJIC loss was a reversible process. Taken together, these data support the hy-
pothesis that disruption of cellecell communication may contribute to the tumor-promoting
effect of inorganic arsenic trioxide.
Copyright ª 2013, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Arsenic remains one of the greatest sources of concern
among environmental toxicants worldwide. Indeed, epide-
miological evidence has shown that long-term exposure to
inorganic arsenic, especially arsenic trioxide (As[III]), is
associated with increased risk of cancer development in
many organs, especially the skin, kidneys, urinary bladder,
liver, and lungs [1e3]. In Tainan County, southern Taiwan,
arsenic contamination has been found in well drinking
water. Increases in cumulated liver cancer mortality
ratesd1.7-fold for males and 2.2-fold for femalesdhave
been documented in the villages of that unique endemic
area [1]. The liver is clearly one of many target organs that
are vulnerable to arsenic toxicity, and chronic arsenic
exposure has been linked to the occurrence of hepatocel-
lular carcinomas (HCCs), as well as many hepatic lesions
such as steatosis, portal fibrosis, and hepatomegaly [4e7].
Gap junctions, formed by oligomerization of connexin
(Cx) proteins, are intercellular membrane channels that
connect the cytoplasmic compartments of adjacent cells,
thereby allowing the direct exchange of signaling molecules
between cells [8]. This process, termed gap junction
intercellular communication (GJIC), is thought to
contribute to tissue homeostasis by maintaining the optimal
rates of cell growth and cell death [9]. It is therefore
conceivable that modulation of cellecell and cellematrix
signaling is involved in cancer development [9].
There is substantial evidence to suggest that Cxs func-
tion as tumor suppressors and that sustained down-
regulation of GJIC may promote tumor formation [9].
Transformed cells and tumors frequently exhibit loss of
GJIC, and mice lacking Cx genes are at an increased risk of
developing both spontaneous and chemically induced tu-
mors [10]. Importantly, disruption of gap junction function
due to altered expression, aberrant localization, or post-
translational modification of connexin proteins appears to
be an early event associated with the mechanisms of many
nongenotoxic carcinogens [11]. As[III] has been shown to be
a potent carcinogen; however, the exact molecular mech-
anism of its carcinogenicity is not understood. Thus, the
first aim of this study was to investigate whether alteration
of GJIC plays a crucial role in arsenics-related hepatic
carcinogenesis. Because arsenic pentoxide (As[V]) is less
toxic than As[III], we used As[V] as another control. In this
study, we chose to use the rat WB-F344 cell line; these cells
predominantly express connexin43 (Cx43) [12].
Gap junctions and adherens junctions, which are made
up of E-cadherins, are often spatially intimately arranged in
cells [13]. Previous studies have provided solid evidence ofsignificant interplay between gap and adherens junctions
[14]. Cx43-mediated gap junctional intercellular commu-
nication is controlled by E-cadherin [15]. On the contrary,
connexin antibodies can inhibit both gap junction and
adherens junction assembly [13,16]. Therefore, these two
types of junctional complexes are closely associated. Wei
et al [17] reported that Cx43 associated with cadherin is
required for gap junction formation in cells.
The cytoplasmic tail of E-cadherin is bound by b-catenin
[18]. b-Catenin, in addition to its function in mediating cell
adhesion, is also involved in intracellular signaling path-
ways, including the Wnt pathway, which upon activation
results in the transcription of a battery of genes known to
promote cellular proliferation and repress differentiation
during embryogenesis and carcinogenesis [19]. The aber-
rant activation of this pathway through loss of cell adhesion
and accumulation of b-catenin in the cytoplasm is thought
to contribute to tumor promotion [19].
Our preliminary results showed that As[III] could signifi-
cantly decrease GJIC. It is therefore interesting to explore
whether Cx43, E-cadherin, or b-catenin exhibit any changes
in mRNA or protein levels after exposure of WB-F344 cells to
arsenics.
Cancer stem cell theory is based on the observation that a
small subpopulation of cells can differentiate into pheno-
typically diverse cancer cells. The existence of cancer stem
cells has been documented in some solid tumors such as
breast and brain cancer. Several studies have shown that
side population cells do exist in hepatoma cell lines such as
Hep3b, Hep Sk1, and HuH7, and that they have the capacity
for self-renewal and multilineage potential. It is believed
that various lineages within a cancer are maintained by
these cancer stem cells, which is the origin of a cancer. WB-
F344 cells are derived from rat liver “oval” cells, which
represent liver progenitor/stem cells in rats. We did not
choose human primary hepatocytes culture, which contains
mainly adult mature hepatocytes and has less Cx43 expres-
sion. In the past, we have reported our results using the WB-
F344 cell line for a study of l,l-bis(p-chlorophenyl)-2,2,2-
trichloroethane (DDT)-related hepatic tumorigenicity [20].Materials and methods
Chemicals
All chemicals used in this study were of the highest avail-
able purity. Potassium chromate and paraformaldehyde
were supplied by Merck (Darmstadt, Germany). D-medium,
fetal bovine serum, and immunoglobulin IgG or IgM Alexa
Arsenics suppress GJIC, Cx43, and E-cadherin 59fluor 488 and 555 were supplied by Gibco (Invitrogen Cor-
poration, Grand Island, NY, USA). Lucifer yellow CH
dilithium salt was supplied by Fluka (Sigma-Aldrich,
Switzerland). TRIzol reagent and BCP (1-bromo-3-
chloropropane) were supplied by the Molecular Research
Center. Dimethyl sulfoxide was supplied by Echo (Miaoli,
Taiwan, R.O.C.). D-(þ)-Glucose, sodium chloride, sodium
bicarbonate, pyruvic acid, and MTT (thiazolyl blue tetra-
zolium bromide) were supplied by Sigma-Aldrich (St. Louis,
MO, USA). Immobilon Western HRP substrate peroxide so-
lution and luminal reagent were supplied by Millipore Cor-
poration (Billerica, MA, USA). High-capacity cDNA power
SYBR green OCR master mix and a reverse transcription kit
were supplied by Applied Biosystems (Foster City, CA, USA).
Cell culture and treatment with chemicals
WB-F344 rat liver epithelial cells [21] were cultured in D-
medium supplemented with 5% fetal bovine serum (Invi-
trogen) and 1% [v/v] penicillin/streptomycin antibiotic.
WB-F344 cells originate from the Fischer 344 male rat; the
cell line is immortalized, diploid and nontumorigenic, with
the phenotypic properties of “oval” cells [21]. The cells
were grown at 37 C in a 5% CO2 incubator before being
used in the different experiments. Confluent cells, grown
on plates, were exposed to various concentrations of indi-
vidual As[III and V]. To prepare the As[III and V] stock so-
lutions, As2O3 and As2O5 powders were dissolved in distilled
H2O then diluted to final concentrations of 100 mM (As[III])
and 3400 mM (As[V]).
As[III and V] cell toxicity assay
The effect of As[III and V]on the survival ofWB-F344 cells was
assessed using an MTT toxicity assay, as described previously
[22]. In brief, cells were plated in 1000 mL ofmedia in 48-well
plates (1 105/well). On the following day, theexperimental
medium containing different As[III] (0 mM, 5 mM, 10 mM,
15 mM, 20 mM, 25 mM, 30 mM, and 35 mM) or As[V] (0 mM, 43 mM,
87 mM, 130 mM, 174 mM, 217 mM, 260 mM, and 304 mM) con-
centrations was added, followed by incubation for 1 day, 2
days, or 3 days. Fifty microliters of MTT solution [2 mg/mL in
phosphate-buffered saline (PBS)]was added to eachwell and
incubated for 4 hours. After careful removal of the media,
150 mL dimethyl sulfoxide was added to each well, and then,
after careful shaking, the absorbance was read at 570 nm
using an ELISA microplate reader (Zenyth 200rt with ADAP
software; Anthos Labtec Instruments, Wals, Austria).
GJIC inhibition assay
The GJIC assay was carried out in 35 mm  10 mm tissue
culture dishes with 100% confluent monolayer cells grown in
2 mL Dulbecco’s modified Eagle’s medium supplemented
with 5% newborn calf serum, 100 U/mL penicillin and
100 mg/mL streptomycin. GJIC was detected using the
scrape loading and dye transfer technique developed by el-
Fouly et al [23]. Assays for different treatments and vehicle
control were run in triplicate tissue culture dishes. Mono-
layer cells with 100% confluence were incubated with the
target compounds for a specific length of time (8 hours) atdifferent concentrations (6.25e50 mM) or for various
lengths of time at constant concentration (12.5 mM). After
exposure to the target compounds, the cells were rinsed
three times with PBS, and 1 mL of lucifer yellow solution
was added to the cell cultures and scrape-loaded with
several scrapes using a steel surgical blade. The dye solu-
tion was left on the cell cultures for 3 minutes then dis-
carded, and the cell cultures were carefully rinsed three
times with PBS to remove the detached cells and back-
ground fluorescence. Several drops of 4% formalin in PBS
were added to fix the cell cultures. An inverted fluores-
cence microscope equipped with a digital camera (Nikon
Eclipse TE 2000-U system, Nikon CoolSnap Image ProPlus;
Nikon Corporation, Tokyo, Japan) was used to record the
migration of the lucifer yellow dye from the edge cells of
the scrape. The migration was measured on a micrograph.
An average value of 30 measurements for each treatment
(10 measurements per dish) was regarded as the migration
of the dye in the cell cultures. The percentage migration of
the dye in the cell cultures exposed to the target com-
pounds was calculated as compared with the migration of
the dye in the vehicle control and was then used to eval-
uate the inhibition of GJIC.
Immunohistochemistry
For immunohistochemical analysis, cells were grown in
complete medium until they reached 90% confluence. After
treatment with As[III and V], cells were washed with PBS,
fixed with 4% paraformaldehyde, and blocked with normal
goat serum. Cells were incubated with E-cadherin (BD
Biosciences, San Jose, CA, USA), b-catenin (Zymed Labo-
ratories, San Francisco, CA, USA), or Cx43 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), diluted 1:1500 in PBS
with 1% (v/v) normal goat serum overnight at 4 C. Cells
were then washed with PBS and incubated with an Alexa
fluor 488- or 555-coupled goat anti-rabbit IgG (H þ L) sec-
ondary antibody [Molecular Probes (Invitrogen, Carlsbad,
CA, USA); diluted 1:800 in PBS] for 45 minutes at 37C.
RNA isolation and reverse transcription-polymerase
chain reaction; real-time polymerase chain
reaction
WB-F344 liver cells were treated with different concen-
trations of As[III] (7 mM, 12.5 mM, and 18 mM) or As[V]
(130 mM, 174 mM, and 217 mM) for 24 hours. To verify the
presence of specific mRNAs of Cx43 and E-cadherin, we
amplified them by reverse transcription-polymerase chain
reaction (RT-PCR), and the GAPDH gene was amplified as a
control. Total RNA of the tissues was extracted using a
single-step technique with TRIzol reagent (Invitrogen) ac-
cording to the manufacturer’s protocol. The extracted viral
RNA was suspended in 25 mL of RNase-free H2O. A volume of
7 mL of the extracted viral RNA was analyzed using a Gene
Quant Pro spectrophotometer (Amersham Biosciences, Pis-
cataway, NJ, USA). RNA purity was determined by calcu-
lating the ratio between the absorbance measured at
260 nm and that measured at 280 nm.
A final volume of 20 mL for the RT reaction consisted of
2 mM MgCl2, 0.2 mM dNTP mix, 10 PCR buffer (500 mM KCl,
60 P.-J. Hsiao et al.100 mM TriseHCl, pH 8.3), 2 mM Random Hexamer, 1 mL
RNase inhibitor (20 U/mL), and 1.25 mL MuLV reverse tran-
scriptase (50 U/mL; Applied Biosystems), and 5 mL of RNA
(equivalent to 0.4 mg), which was incubated at 42C for 45
minutes, and then the reverse transcriptase was inacti-
vated at 95C for 5 minutes.
Real-time amplification was performed using a total re-
action volume of 25 mL. Real-time reactions were carried
out with 12.5 mL SYBR-Green PCR Master Mix (Applied Bio-
systems), 300 nM of each specific primer of Cx43, E-cad-
herin, and GAPDH as described in Table 1, and 2 mL of cDNA.
Reactions were run on the ABI Prism 7000 sequence
detection system (Applied Biosystems) under the following
thermal conditions: 50C for 2 minutes, 95C for 10 mi-
nutes, followed by 40 cycles at 95C for 15 seconds and
60C for 1 minute. Readings were taken at every cycle, and
the logarithm of the increment in fluorescence was plotted
versus the cycle number. The threshold level was fixed at
the same midexponential position for all runs.
For data analysis, the melting temperature, fluores-
cence (dF/dT ) under the melting curves window, and Ct,
which is defined as the fractional cycle number at which
the fluorescence passed the fixed threshold, were selected
as the evaluating parameters in the quantification window.
Each Ct value was obtained by the means of three repli-
cates with a standard deviation of <0.2.Western blot analysis
WB-F344 liver cells were treated with different concen-
trations of As[III] (7 mM, 12.5 mM, and 18 mM) or As[V]
(130 mM, 174 mM, and 217 mM) for 24 hours. After treatment,
the medium was removed, then cells were washed twice
with PBS and lysed with 0.5% sodium dodecyl sulfate (SDS).
Lysates were stored at e80C. Cell lysates were sonicated,
and protein levels were determined using a protein detec-
tion assay (Bio-Rad, Hercules, CA 94547). Sample blue
buffer (30% sucrose, 10% SDS, 0.1% bromophenol blue, 0.2%
dithiothreitol) was added, and the samples were heated for
5 minutes at 95C and loaded onto gels [10% SDS-poly-
acrylamide gel electrophoresis (PAGE)]. SDS-PAGE-
separated proteins were blotted onto a nitrocellulose
membrane (Amersham Biosciences) using a semidry blotter
(VWR), and the membrane was blocked with 5% milk in 1
Tris buffer (10 mmol/L Tris, 150 mmol/L NaCl, 0.5% Tween
20; pH 7.4) for 1 hour at room temperature. The proteins
were probed with the same antibodies as used in the
immunohistochemical studies at 4C overnight, followed by
incubation with horseradish peroxidase-conjugated sec-
ondary antibodies. Protein visualization was carried outTable 1 Nucleotide sequences of the primers used for real-tim
Gene Accession number Forward primer (5
Connexin 43 NM_012567 TCGTGCCGCAATTACA
GAPDH NM_017008 GCAAGAGAGAGGCCC
b-Catenin NM_053357 GCTTGGCTGAACCGT
E-Cadherin NM_031334 GGCCCAGGAGCTGAC
RT-PCR Z reverse transcription-polymerase chain reaction.using an enhanced chemiluminescence kit according to the
manufacturer’s protocol.
Statistical analysis
Means  SEM were calculated, and the data are presented
as a percentage of the control. All data were analyzed by
Sigma Plot 8.0 software (at WareSeeker.com) using a
repeated-measures technique. Real-time quantitative RT-
PCR data were calculated, and the averages and gene
expression levels were analyzed as described by Livak and
Schmittgen [24] and graphed using Microsoft Excel 2000.
Analysis of variance was used to test the hypothesis that
the independent variables (treatment, day, incubation
time, time point) had no effect; tests for contrasts to
compare the different levels of the independent variables
were carried out.
Results
Cytotoxicity of As[III and V] in WB-F344 liver cells
The survival inhibition of WB-F344 liver cells by As[III] was
assessed using theMTTproliferation assay (Fig. 1A).WB-F344
cells were treated with As[III] at various concentrations
(0 mM, 5 mM, 10 mM, 15 mM, 20 mM, 25 mM, 30 mM, and 35 mM),
and the results showed dose- and time- related reductions in
cells survivability. WB-F344 cells were also treated with As
[V] at various concentrations (0 mM, 43 mM, 87 mM, 130 mM,
174 mM, 217 mM, 260 mM, and 304 mM) for 1 day, 2 days, and 3
days (Fig. 1C), and the results showed a gradual decrease in
cell viability in a dose- and time-dependent manner. From
Fig. 1A, it can be seen that the WB-F344 cells exposed to As
[III] at 10e15 mM for 1 day had a survival rate of about
70e80%. Another study was conducted to determine theWB-
F344 cells’ viability at more diluted As[III] concentrations
(0 mM, 2.5 mM, 5 mM, 6.25 mM, 10 mM, 12.5 mM, 15 mM, and
20 mM) for 1 day (Fig. 1B). Again, the results showed a dose-
related pattern; however, the viability was quite similarly
maintained around 80% between 5 mM and 12.5 mMAs[III]. We
chose to use the concentration of 12.5 mM for the following
GJIC study. Similarly, an As[V] concentration of 174 mM
exhibitedminimal cytotoxicity to theWB-F344 cells (Fig. 1C;
*p < 0.01, **p < 0.05).
Concentration- and time-dependent inhibition of
GJIC by As[III] and As[V]
Treatment of WB-F344 cells with As[III] at concentrations of
6.25 mM, 12.5 mM, 25 mM, and 50 mM for 8 hours resulted in ae quantitative RT-PCR.
0e30) Reverse primer (50e30) Size (bp)
ACAA CTGCCCCATGCGATTTTG 78
TCAGTT TTGTGAGGGAGATGCTCAGTGT 75
CACA AAGTTCCGCGTCATCCTGAT 74
AAAC CCAGAGGCTGCGTCACTTTC 82
Figure 1. Cytotoxicity of As[III and V] in WB-F344 liver cells.
The survival inhibition of WB-F344 liver cells by (A) As[III] and
(B) As[V] was assessed using the MTT proliferation assay. Cells
were treated with varying As[III] concentrations (0 mM, 5 mM,
10 mM, 15 mM, 20 mM, 25 mM, 30 mM, and 35 mM) and As[V]
concentrations (0 mM, 43 mM, 87 mM, 130 mM, 174 mM, 217 mM,
260 mM, and 304 mM) for 1 day, 2 days, and 3 days. Each result
was taken as the average of six independent wells. The results
were confirmed after six repeated independent experiments.
Statistical significance was determined using Student t test
(*p < 0.01, **p < 0.05). MTTZ 3-[4,5-dimethylthiazol-2-yl]-2,5
diphenyl tetrazolium bromide.
Arsenics suppress GJIC, Cx43, and E-cadherin 61dose-dependent reduction in GJIC (Fig. 2A). GJIC started to
decrease significantly when the As[III] concentration was
greater than 6.25e12.5 mM. Inhibition of GJIC by As[III]
using the modified scrape loading/dye transfer method
with lucifer yellow fluorescent dye is shown in Fig. 2A. In
Fig. 2B, the results for cells treated with 12.5 mM As[III] for
up to 60 hours show a reduction in GJIC correlated with
exposure time.As[III] treatment effects on the migration of lucifer
yellow dye in scraped WB-F344 liver cells
Representative photographs illustrate As[III]-treated
(Fig. 2C and D) cells and control (Fig. 2E and F). Fig. 2Cand E show phase contrast pictures, and Fig. 2D (0% GJIC)
and 2F(100% GJIC) depict fluorescent pictures.
Reversibility of GJIC inhibition after removal of As
[III]
GJIC was moderately inhibited when WB-F344 cells were
treated with 6.25 mM As[III] for 24 hours (Fig. 2G) when
compared with the control (Fig. 2F; 30 measured lengths of
dye migration for each of these three groups: control,
6.25 mM, 12.5 mM; by one-way analysis of variance,
p < 0.05). After removing the As[III] by washing out from
the dish for 4 hours, the lengths of dye migration in GJIC
were remeasured. Our data showed that WB-F344 cells still
survived very well and started to recover their GJIC at
several areas at the 4th hour (Fig. 2H; white circles). This
GJIC inhibition was a reversible process (Fig. 2G vs.
Fig. 2H).
Expression of Cx43, E-cadherin and b-catenin
analyzed by immunofluorescence staining in
WB-F344 liver cells treated with 12.5 mM As
[III]/174 mM As[V] for 8 hours
The fluorescence density of Cx43 and E-cadherin in either
As[III]-treated (12.5 mM; middle panel in Fig. 3) or As[V]-
treated cells (174 mM; right panel in Fig. 3) was slightly
lower than that of the control under the microscopic ex-
amination in the dark room (left panel in Fig. 3). WB-F344
liver cells exposed to As[III] showed b-catenin nuclear
translocation, as evidenced by heavily stained nuclei when
using the anti-b-catenin antibody (middle panel, bottom in
Fig. 3). However, this nuclear translocation did not occur
when cells were exposed to As[V] (right panel, bottom in
Fig. 3).
Effects of As[III] on Cx43 and E-cadherin mRNA
levels
The relative mRNA expression alterations of Cx43 and
E-cadherin were quantified in WB-F344 liver cells after 1
day As[III] treatment in a dose-dependent manner using
real-time quantitative RT-PCR (7 mM, 12.5 mM, and 18 mM;
Fig. 4A). The means of three independent triplicates of the
target genes were calculated, normalized with their cor-
responding GAPDH values, and expressed as fold changes
compared with nontreated cells (as a control; *p < 0.01,
**p < 0.05). The results show that mRNA of Cx43 was
significantly downregulated in a dose-dependent manner as
compared with the control. mRNA of E-cadherin was also
significantly decreased after exposure to various doses of
As[III].
Western blot analysis of Cx43, E-cadherin, and
b-catenin proteins expression alterations in As
[III]-treated WB-F344 liver cells
Cells were incubated with either medium alone (control) or
various concentrations of As[III] (7 mM, 12.5 mM, and
18.0 mM) for 24 hours. The results showed a significant
Figure 2. Inhibition of GJIC by As[III] using the modified scrape loading/dye transfer method with lucifer yellow fluorescent dye.
(A) Doseeresponse (6.25e50 mM) of inhibition of GJIC after 8 hours of As[III] exposure. (B) Inhibition of GJIC in WB-F344 liver cells
exposed to As[III] showed a time-dependent pattern. Cells were treated with 12.5 mM As[III]. The results represent the means  SD
of at least three independent experiments. (C, D, E, F) Representative photographs illustrating the migration of lucifer yellow dye
in (C, D) As[III]-treated WB-F344 liver cells and (E, F) control. C and E are phase contrast pictures; D and F are fluorescent pictures.
(G, H) After exposure to 6.25 mM As[III] for 24 hours, the GJIC was moderately inhibited(G), which started to retrieve GJIC at several
areas when As[III] was removed for 4 hours (H; white circled). This GJIC inhibition was a reversible process (panel G vs. panel H).
This implies arsenic trioxide can directly suppress GJIC not via released cytokines from As[III] related cytotoxic cell deaths.
GJIC Z gap junction intercellular communication.
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Figure 3. Expression of (A) Cx43, (B) E-cadherin, and (C) b-catenin using immunofluorescence staining in WB-F344 liver cells
treated with 12.5 mM As[III]/174 mM As[V] for 8 hours. The fluorescence density of Cx43, E-cadherin and b-catenin in either As[III]-
(middle panel) or As[V]- (right panel) treated cells was slightly lower (thinner and less bright green cell membranes; yellow circles)
than that of the control (left panel) under the microscopic examination in a dark room. In this immunofluorescence study, arsenic
trioxide did alter the nuclei been heavily stained with anti-b-catenin antibody, indicating significant nuclear translocation
(arrows).
Arsenics suppress GJIC, Cx43, and E-cadherin 63downregulation in Cx43 and E-cadherin at protein levels
correlated with the dosage of As[III] (Fig. 4B).
After exposure to 12.5 mM As[III] for 1 day, 2 days, or 3
days, a statistically significant down-expression of Cx43
and E-cadherin protein levels was found in a time-
dependent pattern (Fig. 4C). However, b-catenin showed
no significant alteration in protein levels, even at higher
As[III] concentrations (Fig. 4B) or with longer exposure
times (Fig. 4C).Effects of As[V] on Cx43 and E-cadherin mRNA
levels
The relative mRNA expression alterations of Cx43 and E-
cadherin were quantified in WB-F344 liver cells after As[V]
treatment in a dose-dependent manner using real-time
quantitative RT-PCR (130 mM, 174 mM, and 217 mM)
(Fig. 5A). The means of three independent triplicates of
the target genes were calculated, normalized with their
corresponding GAPDH values, and expressed as fold
changes compared with nontreated cells (as a control;
*p < 0.01, **p < 0.05). The results show that the mRNAs
were significantly downregulated in a dose-dependent
manner.Western blot analysis of Cx43, E-cadherin, and
b-catenin protein expression alterations in As
[V]-treated WB-F344 liver cells
Cells were incubated with either medium alone (control) or
various concentrations of As[V] (130 mM, 174 mM, and 217 mM)
for 24 hours. The results showed a significant downregulation
of Cx43 and E-cadherin protein levels correlated with the
dosage of As[V] (Fig. 5B). After exposure to 174 mMAs[V] for 1
day, 2 days, and 3 days, a statistically significant down-
expression of Cx43 and E-cadherin protein levels was found
in a time-dependent pattern (Fig. 5C). b-Catenin showed a
minimally decreased protein level when cells were exposed
to very high doses of As[V] (217 mM or 174 mM) for 3 days.Discussion
In this study, we investigated the potential tumor-
promoting activity of As[III] and As[V] in rat hepatic
“stem-like” cells, WB-F344. Our findings include the
following: (1) exposure of cells to As[III] at concentrations
greater than 6.25e12.5 mM for 8 hours could cause GJIC
loss, with inhibition occurring in a dose- and time-
dependent manner, and that this GJIC loss was reversible
Figure 4. (A) The relative mRNA expression alterations of Cx43, E-cadherin and b-catenin were quantified in WB-F344 liver cells
after As[III] treatment in a dose-dependent manner using real-time quantitative RT-PCR (7 mM, 12.5 mM, and 18 mM). Means of
three independent triplicates of the target genes were calculated, normalized with their corresponding GAPDH values, and
expressed as fold changes compared with nontreated cell as a control. Data represent the average of three replicates with their
standard errors (*p < 0.01, **p < 0.05). (B) Western blot analysis of Cx43, E-cadherin and b-catenin protein expression alterations in
As[III]-treated WB-F344 liver cells. Cells were incubated with either medium alone (control) or various concentrations of As[III]
(7 mM, 12.5 mM, and 18.0 mM) for 24 hours. There was significant downregulation of Cx43, E-cadherin and b-catenin mRNA and
protein levels. (C) After exposure to 12.5 mM As[III] for 1 day, 2 days, and 3 days, statistically significant lower expression of Cx43,
E-cadherin and b-catenin protein levels was found in a time-dependent pattern. RT-PCRZ reverse transcription-polymerase chain
reaction.
64 P.-J. Hsiao et al.when As[III] was removed from the dishes for 4 hours; (2) As
[III] concentrations greater than 12.5 mM could reduce Cx43
and E-cadherin mRNA and protein levels, and increased
translocation of b-catenin to the nucleus was observed in
an immunohistochemical staining study; and (3) As[V] at
174 mM could also decrease Cx43 and E-cadherin mRNA and
protein expressiondhowever, there was no change in the
distribution of b-catenin as compared with the control.
Carcinogenesis is a multistep process, including “initia-
tion”, “promotion”, and “metastasis” (“progression”).
Potter [25] suggested that the initiation process prevents
genetically altered stem cells from terminally differenti-
ating, and, at that moment, GJIC restricts the growth of
these cells. However, when exposed to tumor promoters,
which inhibit GJIC, these transformed cells proliferate [26].
Inhibition of GJIC has been shown to be an important part
of the activity of tumor promoters [27]. The main function
of gap junctions is to maintain tissue homeostasis, and a
disruption in intercellular communication may cause the
loss of homeostatic and cell growth control [11]. Our data
clearly demonstrate that the reductions in GJIC werecorrelated with dose (6.25e50 mM) and exposure time
(12e60 hours) of As[III].
DDT inhibits GJIC in WB-F344 rat liver epithelial cells and
is regarded to have liver tumorigenic activity [20]. The
ozonation products of benzo(a)pyrene inhibit cell commu-
nication [28] and are believed to be carcinogenic [29]. It has
been reported that chemicals such as dioxins, poly-
chlorinated aromatic hydrocarbons, and cadmium, which
can promote tumorigenesis, have been linked to decreased
gap junctional intercellular communication in cultured he-
patocytes [29e31]. Several oncogenes have also been re-
ported as inhibiting GJIC [32]. This is the first article claiming
loss of GJIC after WB-F344 cells were exposed to As[III].
The causes of reduced GJIC were further explored in this
study, the results of which demonstrate that, after expo-
sure to arsenic, WB-F344 cells show reduced mRNA and
protein levels in Cx43. Cx43 is the major connexin protein in
WB-F344 cells, and the reduction in GJIC may be due to the
decreased Cx43 gene expression. Because E-cadherin and
b-catenin are structurally linked to Cx43, their gene ex-
pressions were further studied.
Figure 5. (A) The relative mRNA expression alterations of Cx43, E-cadherin and b-catenin were quantified in WB-F344 liver cells
after As[V] treatment in a dose-dependent manner using real-time quantitative RT-PCR (130, 174 and 217 mM). Means of three
independent triplicates of the target genes were calculated, normalized with their corresponding GAPDH values, and expressed as
fold changes compared with nontreated cells (as a control). Data represent the average of three replicates with their standard
errors (*p < 0.01, #p < 0.05). (B) Western blot analysis of Cx43, E-cadherin and b-catenin protein expression alterations in As[V]-
treated WB-F344 liver cells. Cells were incubated with either medium alone (control) or various concentrations of As[V] (130, 174
and 217 mM) for 24 h. (C) After exposure to 174 mM As[V] for 1, 2 and 3 days, statistically-significant down-expression of Cx43,
E-cadherin and b-catenin protein levels was found in a time-dependent pattern.
Arsenics suppress GJIC, Cx43, and E-cadherin 65Hernandez-Blazquez et al [33] concluded that the for-
mation of the E-cadherin complex is required for the for-
mation of gap junctions. Gap junctions and adherens
junctions are often spatially intimately arranged between
cells [13]. Gap-junction-deficient cells, when transfected
with E-cadherin, have revealed increasing GJIC [15]. Jansen
et al [34] reported that the tumor promoters 12-O-tetra-
decanoylphorbol-13-acetate and benzoyl peroxide simul-
taneously alter GJIC and E-cadherin-dependent cell
adhesion. Hence, considerable cross-talk between gap
junctions and adherens junctional complexes does exist.
Our data suggest that mRNA and proteins of Cx43 and
E-cadherin were downregulated after exposure to 12.5 mM
As[III]. This finding is consistent with a previous report,
which stated that Cx43 and E-cadherin are closely linked.
It has been reported that disruption of E-cadherin-
mediated cell adhesion facilitates the translocation of
b-catenin from the adherens junction to the nucleus, where
it could interact with TCF/LEF transcription factors and
increase the expression of downstream genes such as c-jun
and cyclin D1, which are involved in the malignant trans-
formation of cells. On the contrary, reestablishing thefunctional adherin complexdfor example, by forced
expression of E-cadherindresults in reversion from an
invasive to a benign phenotype [35]. Both E-cadherin and b-
catenin are closely linked to hepatocarcinogenesis [36]. In
the literature, a poorer prognosis has been associated with
nuclear accumulation of b-catenin in HCC [37]. Enhanced
nuclear staining has been observed in invasive and intra-
vascular metastatic HCC cancer cells [38]. It is well known
that b-catenin plays an important role in cellecell adhesion
[39] and in the Wnt/wingless signaling pathway [40].
Because a previous study described b-catenin as the key
mediator of the Wnt signaling cascade, which was involved
in hepatic carcinogenesis [41], it was necessary to investi-
gate the role of b-catenin in our study. Our results showed
that the protein levels of b-catenin were unchanged after
exposure to As[III]; however, the nucleus became heavily
stained with anti-b-catenin antibody when WB-F344 cells
were exposed to As[III], indicating a significant trans-
location of b-catenin to the nucleus.
Our data are consistent with previous observations that
exposure of mouse fetuses to inorganic arsenic increases
the risk of producing HCC in offspring [42]. Barker [43] also
66 P.-J. Hsiao et al.proposes a hypothesis that some bad influences could cause
permanent forms of damage in the embryo or fetus, which
have been linked to diseases in adult life.
Previous epidemiological studies have provided strong
evidence that arsenic trioxide is linked to various cancers.
The exact mechanisms are still unknown. The recent
literature reports that arsenic trioxide has been used in
treating leukemia patients [44]. These results seem
confusing and conflicting. However, radiation and many
chemotherapy drugs (such as alkylating agents, anthracy-
clines, or cisplatin) can both treat cancers or increase the
risk of developing second cancers [45].
Our results clearly demonstrate that As[III] at lower con-
centrations andAs[V] at higher concentrations can causeGJIC
loss, which is a common phenomenon when hepatocytes are
exposed to many tumor-promoting agents. Our data are
consistent with the idea that As[V] is less toxic or tumorigenic
than As[III]. From our results, the biological effects of rat
hepatic “stem-like” cells’ exposure to low-dose (6e12.5 mM)
arsenic trioxidewere found to cause GJIC loss associatedwith
decreased expression of Cx43 and E-cadherin and nuclear
translocation of b-catenin. Decreased Cx43 and E-cadherin
protein levels caused directly by As[III] may lead to an un-
stable gap junction and loss of intercellular communication.
Loss of GJIC is an additional mechanism of arsenic trioxide-
related tumor-promoting effects. Alteration of GJIC is prob-
ably not caused by inflammatory cytokines released from
arsenics-related cytotoxic cell deaths. Based on our data, we
believe notorious arsenic trioxide is involved in hepatic tumor
promotion, but not in its initiation. However, more experi-
ments must be performed on human liver stem/progenitor
cells prior to when we can draw such a conclusion.
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